Retinal vein occlusions in patients taking warfarin

Ophthalmology

Volumn 111, Issue 6, 2004, Pages 1196-1200

  Browning, David J ^a   Fraser, Christina M ^a  

^a Charlotte Eye   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; WARFARIN;

AGE DISTRIBUTION; ANTICOAGULATION; ANTITHROMBIN III DEFICIENCY; EYE COLOR; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFORMATION RETRIEVAL; LABORATORY TEST; LUPUS ERYTHEMATOSUS; MEDICAL RECORD; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; REVIEW; SAMPLE SIZE; SEX RATIO; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ACUITY;

EID: 2942579195     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2003.09.047     Document Type: Article

References (16)

1. Hayreh S.S. Pathogenesis of occlusion of the central retinal vessels. Am J Ophthalmol. 72:1971;998-1011
2. Cobo-Soriano R., Sanchez-Ramon S., Aparicio M.J., et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors a prospective case-control study. Am J Ophthalmol. 128:1999;725-732
3. Glueck C.J., Bell H., Vadlamani L., et al. Heritable thrombophilia and hypofibrinolysis, possible causes of retinal vein occlusion. Arch Ophthalmol. 117:1999;43-49
4. Biousse V., Newman N.J., Sternberg P. Jr. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinemia. Am J Ophthalmol. 124:1997;257-260
5. Vannas S., Orma H. Experience of treating retinal venous occlusion with anticoagulant and antisclerosis therapy. Ama Arch Ophthalmol. 58:1957;812-828
6. Vannas S., Raitta C. Microcirculatory disturbances of occlusive diseases of the eye. Doc Ophthalmol. 33:1972;345-366
7. Bhagat N., Goldberg M.F., Gascon P., et al. Central retinal vein occlusion report of two familial cases. Eur J Ophthalmol. 9:1999;181-195
8. Ezekowitz M.D. Anticoagulation management of valve replacement patients. J Heart Valve Dis. 11:(suppl 1):2001;S56-60
9. Hull R.D., Raskob G.E., Hirsh J., et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 315:1986;1109-1114
10. Vannas S., Raitta C. On anticoagulant treatment of central venous occlusion of the retina. [in German] Acta Ophthalmol (Copenh). 46:1968;730-735
11. Brouwer M.A., Verheugt F.W. Oral anticoagulation for acute coronary syndromes. Circulation. 105:2002;1270-1274
12. Hayreh S.S., Zimmerman B., McCarthy M.J., Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001:2001;61-77
13. Ririe D.G., Cosgriff T.M., Martin B. Central retinal vein occlusion in a patient with familial antithrombin III deficiency case report. Ann Ophthalmol. 11:1979;1841-1845
14. Bhan A., Rennie I.G., Higenbottam T.W. Central retinal vein occlusion associated with primary pulmonary hypertension. Retina. 21:2001;83-85
15. Keenan J.M., Dodson P.M., Kritzinger E.E. Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion? Eye. 7:1993;407-410
16. Chen H.C., Wiek J., Gupta A., et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol. 82:1998;162-167